ABT-089, but not ABT-107, ameliorates nicotine withdrawal-induced cognitive deficits in C57BL6/J mice

Por Yildirim, Emre, Connor, David A., Gould, Thomas J.
Publicado no Behav Pharmacol (2015)

Terlipressin and albumin for type 1 hepatorenal syndrome: does bacterial infection affect the response?

Por Altun, Reskan, Korkmaz, Murat, Yıldırım, Emre, Öcal, Serkan, Akbaş, Enver, Selçuk, Haldun
Publicado no Springerplus (2015)

Dissociation of Tolerance and Nicotine Withdrawal-Associated Deficits in Contextual Fear

Por Gould, Thomas J., Wilkinson, Derek S., Yildirim, Emre, Blendy, Julie A., Adoff, Michael D.
Publicado em 2014

Glucagon‐like peptide‐1 receptor expression in the human eye

Por Hebsgaard, Josephine B., Pyke, Charles, Yildirim, Emre, Knudsen, Lotte B., Heegaard, Steffen, Kvist, Peter H.
Publicado no Diabetes Obes Metab (2018)

Nicotine Shifts the Temporal Activation of Hippocampal Protein Kinase A and Extracellular Signal-Regulated Kinase 1/2 to Enhance Long-Term, but not Short-term, Hippocampus-Dependen...

Por Gould, Thomas J., Wilkinson, Derek S., Yildirim, Emre, Poole, Rachel L. F., Leach, Prescott T., Simmons, Steven J.
Publicado em 2014

Impact of patient characteristics on efficacy and safety of once-weekly semaglutide versus dulaglutide: SUSTAIN 7 post hoc analyses

Por Pratley, Richard E, Aroda, Vanita R, Catarig, Andrei-Mircea, Lingvay, Ildiko, Lüdemann, Jörg, Yildirim, Emre, Viljoen, Adie
Publicado no BMJ Open (2020)

The Duration of Nicotine Withdrawal-Associated Deficits in Contextual Fear Conditioning Parallels Changes in Hippocampal High Affinity Nicotinic Acetylcholine Receptor Upregulation

Por Gould, Thomas J., Portugal, George S., André, Jessica M., Tadman, Matthew P., Marks, Michael J., Kenney, Justin W., Yildirim, Emre, Adoff, Michael
Publicado em 2012

Superior weight loss with once-weekly semaglutide versus other glucagon-like peptide-1 receptor agonists is independent of gastrointestinal adverse events

Por Lingvay, Ildiko, Hansen, Thomas, Macura, Stanislava, Marre, Michel, Nauck, Michael A, de la Rosa, Raymond, Woo, Vincent, Yildirim, Emre, Wilding, John
Publicado no BMJ Open Diabetes Res Care (2020)

Real-world efficacy and safety of Ledipasvir + Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience

Por Değertekin, Bülent, Demir, Mehmet, Akarca, Ulus S., Kani, Haluk Tarık, Üçbilek, Enver, Yıldırım, Emre, Güzelbulut, Fatih, Balkan, Ayhan, Vatansever, Sezgin, Danış, Nilay, Demircan, Melek, Soylu, Aliye, Yaras, Serkan, Kartal, Aysun, Kefeli, Ayşe, Gündüz, Feyza, Yalçın, Kendal, Erarslan, Elife, Aladağ, Murat, Harputluoğlu, Murat, Özakyol, Ayşegül, Temel, Tuncer, Akarsu, Mesut, Sümer, Hale, Akın, Mete, Albayrak, Bülent, Sen, İlker, Alkım, Hüseyin, Uyanıkoğlu, Ahmet, Irak, Kader, Öztaşkın, Sinem, Uğurlu, Çağrı Burak, Güneş, Şevkican, Gürel, Selim, Nuriyev, Kenan, İnci, İsmail, Kaçar, Sabite, Dinçer, Dinç, Doğanay, Levent, Göktürk, Hüseyin Savaş, Mert, Ali, Coşar, Arif Mansur, Dursun, Hakan, Atalay, Roni, Akbulut, Sabiye, Balkan, Yasemin, Koklu, Hayrettin, Şimşek, Halis, Özdoğan, Osman, Çoban, Mehmet, Poturoğlu, Şule, Ayyıldız, Talat, Yapalı, Suna, Günsar, Fulya, Akdoğan, Meral, Özenirler, Seren, Akyıldız, Murat, Sezgin, Orhan, Özdoğan, Osman, Kaymakoğlu, Sabahattin, Beşışık, Fatih, Karasu, Zeki, İdilman, Ramazan
Publicado no Turk J Gastroenterol (2020)